Poor response to erythropoietin

doi:10.1136/bmj.311.7005.633a

From trainee to consultant, BMJ Group offers doctors around the world tailored information, special events, learning resources and recruitment services at every step along their career path.

... by doctors, for doctors, for patients
We are open for entries!

Online learning

BMJ Learning

High-quality CME / CPD for doctors and other healthcare professionals. BMJ Learning features hundreds of accredited, peer-reviewed learning modules in text, video, and audio formats. Find out more

Courses and Qualifications

BMJ Masterclasses

BMJ Masterclasses, led by experts, help clinicians to use the latest evidence and recent guidelines in practice and meet their CPD/CME requirements. Find out more

Exam Preparation

The leading provider of online exam preparation, helping over 167,000 healthcare professionals to pass their exams. Find out more

onExamination

Search all BMJ comment articles:

From

Limit by

Access to the full text of this article requires a subscription or payment. Please log in or subscribe below.

Judith Strachan,
Laura Fleming,
John Dick,
Iain Henderson,
Callum Fraser,
Michael Jones,
Ellon McGregor

Senior biochemist Research fellow Senior registrar Consultant Top grade scientist, biochemical medicine Consultant Consultant, renal medicine Ninewells Hospital and Medical School, Dundee Teaching Hospitals NHS Trust, Dundee DD1 9SY

EDITOR,--Iain C MacDougall's editorial on poor response to treatment with erythropoietin outlines a rational approach to this problem.1 We agree with his scheme of how to investigate and manage patients who apparently show resistance to erythropoietin but would strongly advocate one further investigation--namely, assay of plasma erythropoietin concentrations in such patients. …